Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
92.41
+20.14 (27.87%)
At close: Oct 30, 2025, 4:00 PM EDT
92.00
-0.41 (-0.44%)
After-hours: Oct 30, 2025, 7:57 PM EDT
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $11.52 billion as of October 30, 2025. Its market cap has increased by 334.48% in one year.
Market Cap
11.52B
Enterprise Value
12.38B
1-Year Change
334.48%
Ranking
Category
Stock Price
$92.41
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $11.52B, an increase of 328.32%. That is a compound annual growth rate of 22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 11.52B | 205.31% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.14B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 237.42B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |